BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/6/2026 4:31:58 AM | Browse: 2 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 113748
Country Italy
Category Medicine, General & Internal
Manuscript Type Review
Article Title Serum biomarkers in diabetic kidney disease: A comprehensive narrative review
Manuscript Source Invited Manuscript
All Author List Guido Gembillo, Luca Soraci, Giuseppe Spadaro, Rossella Messina, Felicia Cuzzola, Michela Calderone, Maria F Ricca, Simona Di Piazza, Flavia Sudano, Maria E Gambuzza, Maria Princiotto, Lorenzo Lo Cicero and Domenico Santoro
Funding Agency and Grant Number
Corresponding Author Guido Gembillo, Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, Messina 98125, Sicilia, Italy. guidogembillo@live.it
Key Words Diabetic nephropathy; Chronic kidney disease; Albuminuria; Renal function; Inflammation markers; Diabetes; Biomarkers
Core Tip Diabetic kidney disease is the main cause of end-stage renal disease, yet early detection is limited by the poor sensitivity of serum creatinine and estimated glomerular filtration rate. Novel biomarkers such as cystatin C, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and tumor necrosis factor receptors show superior accuracy for identifying early damage and predicting progression. Emerging markers, including adropin, soluble urokinase plasminogen activator receptor, monocyte chemoattractant protein-1, chitinase-3-like protein 1, endostatin, zinc-α2-glycoprotein, PromarkerD, and microRNAs, provide additional value for risk stratification and personalized therapy. Integration of validated multi-marker panels may transform monitoring and management, improving outcomes for patients with diabetes.
Citation Gembillo G, Soraci L, Spadaro G, Messina R, Cuzzola F, Calderone M, Ricca MF, Di Piazza S, Sudano F, Gambuzza ME, Princiotto M, Lo Cicero L, Santoro D. Serum biomarkers in diabetic kidney disease: A comprehensive narrative review. World J Diabetes 2026; In press
Received
2025-09-02 04:54
Peer-Review Started
2025-09-05 00:07
First Decision by Editorial Office Director
2025-10-17 07:10
Return for Revision
2025-10-17 07:10
Revised
2025-12-05 18:01
Publication Fee Transferred
Second Decision by Editor
2026-02-06 02:46
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-06 04:31
Articles in Press
2026-02-06 04:31
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com